Reassessing high-dose ranibizumab in the era of durable anti-VEGF therapy. [PDF]
Front Ophthalmol (Lausanne)Cheng CK, Tsai CJ, Bai CH.
europepmc +1 more source
A comparative study on the efficacy and safety of biosimilar (Rimmyrah) and reference ranibizumab in patients with diabetic macular edema. [PDF]
Front PharmacolZhai G, Ren X, Xu B, Mi D.
europepmc +1 more source
Cost-effectiveness analysis of the use of faricimab in diabetic macular edema in China. [PDF]
J Comp Eff ResShi F +6 more
europepmc +1 more source
Switching From Intravitreal Ranibizumab (Lucentis) to Biosimilar Ranibizumab (Ongavia) Injections: Insights From a Tertiary Care Eye Centre. [PDF]
CureusSourla E, Zaheer N, Chavan R.
europepmc +1 more source
Measurement of Acute Intraocular Pressure Elevation Immediately After Intravitreal Anti-VEGF Injection and Analysis of Prefilled Syringe Accuracy. [PDF]
Clin OphthalmolItoh K, Negishi M.
europepmc +1 more source
How to treat recurrences after Avastin treatment for neovascular AMD: stick to Avastin or switch to Lucentis? [PDF]
, 2008 Haritoglou, Christos +4 more
core +1 more source
Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience-ROSE Korea Study. [PDF]
Sci RepSong JR +11 more
europepmc +1 more source
Alpha-Gal Syndrome Allergy to Intravitreal Administration of Anti-Vascular Endothelial Growth Factor Agents. [PDF]
J Vitreoretin DisZhang E, Bylund R, Zhang A, Massop D.
europepmc +1 more source
The Effect of Intravitreal Ranibizumab Injection on Retinal Nerve Fiber Layer Thickness and Optic Disc Parameters. [PDF]
J Clin MedOngun GT, Yağcı R.
europepmc +1 more source
Intravitreal Ranibizumab Injections Significantly Influence Retinal Venous Calibre in Patients With Diabetic Macular Oedema. [PDF]
J OphthalmolChehade LK +5 more
europepmc +1 more source